Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (8)

2024

  1. Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human

    Vascular Pharmacology, Vol. 155

2023

  1. Targeting IL-11 system as a treatment of pulmonary arterial hypertension

    Pharmacological research, Vol. 197, pp. 106985

2018

  1. JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study

    Thorax, Vol. 73, Núm. 6, pp. 519-529

  2. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology

    Respiratory Research, Vol. 19, Núm. 1

  3. Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/ perfusion matching

    PLoS ONE, Vol. 13, Núm. 1

2016

  1. Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries

    Clinical Science, Vol. 130, Núm. 20, pp. 1823-1836

2014

  1. Ceramide mediates acute oxygen aensing in vascular tissues

    Antioxidants and Redox Signaling, Vol. 20, Núm. 1, pp. 1-14

2013

  1. Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis

    Thorax, Vol. 68, Núm. 10, pp. 938-948